| ReNeuron | |
| Type: | Public company |
| Foundation: | 1997 |
| Location: | Surrey, England, UK |
| Key People: | chairman = Trevor Jones |
| Industry: | Stem cell research & development |
| Homepage: | reneuron.com |
ReNeuron is a UK-based stem cell research company whose shares are listed on the Alternative Investment Market. Its focus is on the development of stem-cell therapies targeting areas of poorly-met medical need, including peripheral arterial disease, strokes, and retinal diseases.
ReNeuron is testing the effects of neural stem cells on spinal cords for neuroregeneration.[1] They are also testing the use of fetal stem cells on stroke patients.[2]